학술논문
Azacitidine, Venetoclax, and Gilteritinib in Newly Diagnosed and Relapsed or Refractory FLT3 -Mutated AML
Document Type
Article
Author
Short, N.J.; Daver, N.; Dinardo, C.D.; Kadia, T.; Nasr, L.F.; MacAron, W.; Yilmaz, M.; Borthakur, G.; Montalban-Bravo, G.; Garcia-Manero, G.; Issa, G.C.; Chien, K.S.; Jabbour, E.; Nasnas, C.; Matthews, J.; Stojanik, C.J.; Abramova, R.; Thankachan, J.; Konopleva, M.; Kantarjian, H.; Ravandi, F.; Huang, X.; Qiao, W.; Patel, K.P.
Source
In: Journal of Clinical Oncology . (Journal of Clinical Oncology, 1 May 2024, 42(13):1499-1508)
Subject
Language
English
ISSN
15277755
0732183X
0732183X